Arrive

Curated by Signal

Provider of an AI-based drug development platform for researchers

Overview

Provider of an AI-based drug development platform for researchers. The platform uses AI technology to analyze multi-omic data and cell characterization. The system has the feature to analyze patterns in data for R&D purposes. The company aims to conduct rapid image analysis of cells and assays for drug development.

Key facts

Founded: 2020
Headquarters: United States
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

EEG Store
Provider of neurofeedback software suite for live monitoring and training in clinical settings
Health TechnologyGainesville, United States
AthleteInMe
Online resource platform about fitness and wellness
Health TechnologyPhoenix, United States
Healthcare IQ
Hospital Financial & Operational Data Management
Health TechnologyPalmetto, United States

About Arrive

What does Arrive do?

Provider of an AI-based drug development platform for researchers.

Where is Arrive headquartered?

Arrive is headquartered in United States.

When was Arrive founded?

Arrive was founded in 2020.

Which sector is Arrive in?

Arrive operates in Health Technology.

Who are Arrive's competitors?

Companies similar to Arrive include EEG Store, AthleteInMe, and Healthcare IQ.